Minerva Neurosciences to Present at Citi's 15th Annual BioPharma Virtual Conference
02 sept. 2020 08h30 HE
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...